Cargando…
HA/HSA co-modified erlotinib–albumin nanoparticles for lung cancer treatment
BACKGROUND: Aim of this study was to prepare the hyaluronic acid and human serum albumin modified erlotinib nanoparticles (ERT-HSA-HA NPs) delivery system by a precipitation method. METHODS: ERT-HSA-HA NPs were characterized for physical properties, such as morphology and particle size, and in vitro...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061760/ https://www.ncbi.nlm.nih.gov/pubmed/30087553 http://dx.doi.org/10.2147/DDDT.S169734 |